- Home
- STSS
as 10-07-2025 3:30pm EST
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | MELVILLE |
| Market Cap: | 186.3M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.36 - $1248.27 | Next Earning Date: | 11-13-2025 |
| Revenue: | $222,722 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Sharps Technology Inc. News
STSS Breaking Stock News: Dive into STSS Ticker-Specific Updates for Smart Investing
Cryptonews
5 days ago
Sharps Technology Unveils $100M Solana Buyback – Are Treasury Firms Turning Sour on SOL?
Benzinga
6 days ago
Sharps Technology Teams Up With Crypto.com To Grow Solana Strategy
MT Newswires
6 days ago
Sharps Technology Launches Up to $100 Million Stock Repurchase Plan
PR Newswire
6 days ago
Sharps Technology Announces $100 Million Stock Repurchase Program
Cryptonews
a month ago
Altcoin Season Intensifies as Pudgy Penguins, Solana, Jupiter Rally – Here’s Why
decrypt
a month ago
Morning Minute: BlackRock Wants To Tokenize Its ETFs
MT Newswires
a month ago
Sharps Technology Enters Partnership With Pudgy Penguins
ACCESS Newswire
3 months ago
Q2 Virtual Investor Summit: Presentations Available Now
Compare STSS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STSS Sharps Technology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.